Key facts
- It has raised $5.5M across 1 recorded rounds; the latest was Later Stage VC (Series A) ($60K) in May 2025.
- Notable investors include Creative Destruction Lab, US National Science Foundation, University of Toronto Entrepreneurship, VU Venture Partners, Audacious Capital — 16 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for HEARTio
Funding rounds
1 roundsAbout HEARTio
Developer of a digital diagnostic device designed to help clinicians identify cardiovascular disease effectively. The company's device utilizes artificial intelligence in conjunction with the electrocardiogram to develop deep learning algorithms focused on individualized predictions through identifying arterial stenosis, enabling medical professionals to effectively stratify patient risk and make admission or discharge decisions.
- Industry
- Diagnostic Equipment
- Sector
- Healthcare
- HQ
- Pittsburgh, PA, United States
- Founded
- 2018
- Employees
- 7
- Website
- heartio.ai/
- Ownership
- Privately Held (backing)
HEARTio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HEARTio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HEARTio in its N-PORT filings yet. We sweep new filings monthly.